Relative sensitivity of parkin and other cysteine-containing enzymes to stress-induced solubility alterations.
Loss of parkin function is a predominant cause of familial Parkinsonism. Emerging evidence also suggests that parkin expression variability may confer a risk for sporadic Parkinson disease. We have recently demonstrated that a wide variety of Parkinson disease-linked stressors, including dopamine (DA), induce parkin solubility alterations and promote its aggregation within the cell, a phenomenon that may underlie the progressive susceptibility of the brain to degeneration. The vulnerability of parkin to stress-induced modification is likely due to its abundance of cysteine residues. Here, we performed a comprehensive mutational analysis and demonstrate that Cys residues residing both within and outside of the RING-IBR (in between RING fingers)-RING domain of parkin are important in maintaining its solubility. The majority of these Cys residues are highly conserved in parkin across different species and potentially fulfil important structural roles. Further, we found that both parkin and HHARI (human homologue of Drosophila ariadne), another RING-IBR-RING-type ubiquitin ligase, are comparably more susceptible to solubility alterations induced by oxidative and nitrosative stress when compared with other non-RING-IBR-RING Cys-containing enzymes. However, parkin appears to be uniquely sensitive to DA-mediated stress, the specificity of which is likely due to DA modification of 2 Cys residues on parkin (Cys-268 and Cys-323) that are distinct from other RING-IBR-RING members.
Wong
Esther S P
ES
Neurodegeneration Research Laboratory and Parkinson's Disease and Movement Disorders Center, National Neuroscience Institute, Singapore 308433.
Tan
Jeanne M M
JM
Wang
Cheng
C
Zhang
Zhenshui
Z
Tay
Shiam-Peng
SP
Zaiden
Norazean
N
Ko
Han Seok
HS
Dawson
Valina L
VL
Dawson
Ted M
TM
Lim
Kah-Leong
KL
D000818:Animals; D045744:Cell Line, Tumor; D003545:Cysteine / Q000737:chemistry*; D004252:DNA Mutational Analysis; D004298:Dopamine / Q000378:metabolism; D004330:Drosophila; D006801:Humans; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D012995:Solubility; D013045:Species Specificity; D044767:Ubiquitin-Protein Ligases / Q000737:chemistry / Q000502:physiology*
D044767:Ubiquitin-Protein Ligases; C111567:parkin protein; D003545:Cysteine; D004298:Dopamine